Empa decreased INaL in mouse cardiomyocytes obtained from HF models with reduced [10] and preserved [9] ejection fraction, as well as in ventricular myocytes from patients with aortic stenosis [8]: effects that were attributed to an empa-induced CaMKII inhibition [8,9]. This evidence concerns the gene CAMK2G and aortic stenosis.